Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P19532
UPID:
TFE3_HUMAN
Alternative names:
Class E basic helix-loop-helix protein 33
Alternative UPACC:
P19532; A8MZL6; Q5JU74; Q92757; Q92758; Q99964
Background:
Transcription factor E3, also known as Class E basic helix-loop-helix protein 33, is a pivotal regulator of lysosomal biogenesis and immune response. It binds E-box sequences to activate gene expression, playing a crucial role in cellular responses to nutrient availability, pluripotency of stem cells, and differentiation processes. Its activity is modulated by MTOR through phosphorylation, influencing its localization and function.
Therapeutic significance:
The protein is implicated in Intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies, highlighting its critical role in development and growth. Understanding the role of Transcription factor E3 could open doors to potential therapeutic strategies for this and related disorders.